Dry Blood Allergy Testing

Microarray Allergy Testing is easy for Clinicians to utilize 

Test as early as 3 months!

Simple in office finger-stick blood collection. 

 Patients do not need to stop medications.

Formulate a treatment plan and decide if and when a referral is appropriate.

Early Diagnosis 

baby
Identifying a patient’s triggers can minimize exposure to allergens and reduce symptoms.
90% of asthmatic children have ALLERGIC TRIGGERS Common symptoms include:

Cough      Dyspnea

Wheeze      Chest Tightness

Targeted treatment requires targeted diagnosis

Your patients with rhinitis symptoms have likely already failed on an over-the-counter NSA
Use normal test results to aid compliance with medications effective in non-allergic disease (decongestants, intranasal steroids)

Positive and Negative Results

pie chart

POSITIVE

Identity specific allergens to reduce exposure.

Formulate an appropriate therapy plan based on objective evidence indicating an allergic cause.
Decide if and when referral is appropriate.

NEGATIVE

Rule out allergies and get to the underlying cause

Formulate an appropriate treatment plan based on objective evidence indicating a non-allergic cause.

Decide if and when referral is appropriate!

WITH SPECIFIC IGE TESTING, DIFFERENTIATE THE DIAGNOSIS AND TARGET THE TREATMENT!
  • Differentiate allergic from non-allergic etiologies
  • Select a targeted treatment for allergic and non-allergic rhinitis
  • Reduce exposure to specific allergic triggers
  • Guide timely and appropriate referrals, if necessary
NSAs are not effective in non-allergic rhinitis

BpG842W

  • Non-sedating antihistamines and leukotriene receptor antagonists will only work if the symptoms are caused by histamines or leukotrienes.
  • Non-sedating antihistamines and leukotriene antagonists do not work in non-allergic Rhinitis.

 

It’s possible to provide a clinician with a comprehensive profiles test for 26 common food allergens, 37 common inhalant allergens, or 63 combined food & inhalant allergens…from a single spot of dried blood.

 

The power of the microarray technology does not require the enzymatic enhancement of the protein IgE-allergen binding signal. Therefore, it is possible to detect and measure the actual amount of IgE binding, resulting in a true report of allergic sensitivity.

By running all allergens simultaneously in triplicate, including positive and negative controls, well-to-well variability is eliminated. This further enables highly precise quantification of the relative sensitivity to each of the allergens. In effect, it is a personalized heat map of allergic sensitivity.

 

 

http___spiriplex.com_wp-content_uploads_2018_04_Allergenex-Combined-Profile-sample-report

 

CONTACT US